$Adicet Bio (ACET.US)$Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement 1 MINUTE AGO, 7:10 AM EST VIA BUSINESSWIRE
$Adicet Bio (ACET.US)$ Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement Wednesday, 5th February at 7:10 am Adicet Bio, Inc. (NASDAQ: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ADI-001 for ...
Bear trap : and down